Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Advertising Studies Move Forward Along Several Broad Fronts

Advertisement

Related Content

The Drug Olympics: FDA To Test Consumer Comprehension Of Composite Endpoints
DTC Comparative Ads Will Likely Bloom; FDA Studies How To Evaluate New Species
FDA Tracking Tweets, Blog Posts To Gauge Reach Of Drug Safety Communications
DDMAC's Creative Minds Generate Fictitious Drug Names
DDMAC's Creative Minds Generate Fictitious Drug Names
FDA Advertising Studies Will Examine Website Formatting, Patient Testimonials, Outside Links
FDA's Advertising Studies Expand To Internet Spots, Disease Awareness
Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising
“Brief Summary” Format Changes: FDA Gets Proof of Principle In First Study
FDA Advertising Oversight Will Consider Impact Of “Puppies” And The Internet

Topics

Advertisement
UsernamePublicRestriction

Register

PS053351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel